Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula
British journal of surgery2012Vol. 99(6), pp. 754–760
Citations Over TimeTop 10% of 2012 papers
Sarah L. Gans, Henderik L. van Westreenen, Jordy J. S. Kiewiet, E RAUWS, Dirk J. Gouma, Marja A. Boermeester
Abstract
There is no solid evidence that somatostatin analogues result in a higher closure rate of pancreatic fistula compared with other treatments.
Related Papers
- → Effect of postoperative utilization of somatostatin on clinical outcome after definitive surgery for duodenal fistula(2023)2 cited
- → High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25(1981)120 cited
- → Glucose Modulation of Somatostatin and LHRH Release from Rat Hypothalamic Fragments in vitro(1984)48 cited
- [High biological activity of the synthetic counterparts of hypothalamic somatostatin-28 and somatostatin-25].(1980)
- → Somatostatin Receptor Agents(2007)